Early, encouraging data for glioblastoma treatment reported at ASCO
Glioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0 All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival. Glioblastoma multiforme is the most aggressive type …
Early, encouraging data for glioblastoma treatment reported at ASCO Read More »









